|
ATP6V0A2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.612820E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.909200E-01 |
| Normal-vs-Stage2 |
2.970200E-01 |
| Normal-vs-Stage3 |
2.466000E-01 |
| Normal-vs-Stage4 |
9.139000E-01 |
| Stage1-vs-Stage2 |
6.616600E-01 |
| Stage1-vs-Stage3 |
5.575000E-01 |
| Stage1-vs-Stage4 |
6.145000E-01 |
| Stage2-vs-Stage3 |
9.456000E-01 |
| Stage2-vs-Stage4 |
4.587800E-01 |
| Stage3-vs-Stage4 |
4.452400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.473800E-01 |
| Normal-vs-AfricanAmerican |
1.720410E-02 |
| Normal-vs-Asian |
8.026300E-02 |
| Caucasian-vs-AfricanAmerican |
2.048500E-02 |
| Caucasian-vs-Asian |
2.427200E-01 |
| AfricanAmerican-vs-Asian |
9.062100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.670400E-01 |
| Normal-vs-Female |
1.516230E-01 |
| Male-vs-Female |
4.554400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.351000E-01 |
| Normal-vs-Extreme_Weight |
6.090200E-01 |
| Normal-vs-Obese |
9.657900E-02 |
| Normal-vs-Extreme_Obese |
6.193200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.631200E-01 |
| Normal_Weight-vs-Obese |
3.243800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.826200E-01 |
| Extreme_Weight-vs-Obese |
4.350100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.097000E-01 |
| Obese-vs-Extreme_Obese |
2.481000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.041360E-01 |
| Normal-vs-Age(41-60Yrs) |
5.007600E-02 |
| Normal-vs-Age(61-80Yrs) |
6.019000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.670060E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.717400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.535400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.956000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.399040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.664090E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.515600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.300980E-01 |
| Normal-VS-Type2 PRCC |
8.143400E-01 |
| Normal-VS-KIRP CIMP |
4.220200E-01 |
| Normal-VS-Unclassified PRCC |
1.164180E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.393000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.969200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.069800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.832800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.050600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.367800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.229800E-01 |
| Normal-vs-N1 |
7.276100E-02 |
| Normal-vs-N2 |
7.116000E-01 |
| N0-vs-N1 |
1.878340E-02 |
| N0-vs-N2 |
7.867000E-01 |
| N1-vs-N2 |
2.642800E-01 |
|
|
